UBS AG - NEPHROGENEX INC ownership

NEPHROGENEX INC's ticker is NRXGQ and the CUSIP is 640667101. A total of 15 filers reported holding NEPHROGENEX INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AG ownership history of NEPHROGENEX INC
ValueSharesWeighting
Q3 2014$7,000
+250.0%
1,466
+521.2%
0.00%
Q1 2014$2,0002360.00%
Other shareholders
NEPHROGENEX INC shareholders Q3 2014
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,326,826$6,210,0003.12%
Knoll Capital Management, LLC 50,000$234,0000.09%
FIRST NEW YORK SECURITIES LLC /NY 24,314$113,790,0000.08%
LMR Partners LLP 147,250$689,0000.06%
Visium Asset Management, LP 477,000$2,232,0000.03%
First Western Capital Management Co 13,100$61,0000.02%
STONERIDGE INVESTMENT PARTNERS LLC 19,125$90,0000.01%
Ground Swell Capital, LLC 756$4,0000.01%
UBS AG 1,466$7,0000.00%
BANK OF AMERICA CORP /DE/ 9,100$43,0000.00%
View complete list of NEPHROGENEX INC shareholders